Caprylic/Capric Triglyceride
CAS No. 65381-09-1
Caprylic/Capric Triglyceride( —— )
Catalog No. M24665 CAS No. 65381-09-1
Caprylic/Capric Triglyceride is the triglycerides and esters prepared from fractionated vegetable oil sources and fatty acids from coconuts and palm kernel oils.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | 65 | In Stock |
|
Biological Information
-
Product NameCaprylic/Capric Triglyceride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCaprylic/Capric Triglyceride is the triglycerides and esters prepared from fractionated vegetable oil sources and fatty acids from coconuts and palm kernel oils.
-
DescriptionCaprylic/Capric Triglyceride is the triglycerides and esters prepared from fractionated vegetable oil sources and fatty acids from coconuts and palm kernel oils. Which is used as a food additive and used in cosmetics. Caprylic/Capric Triglyceride possesses excellent oxidation stability.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65381-09-1
-
Formula Weight464.63
-
Molecular FormulaC24H48O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCCCCCCCCC(OCC(O)CO)=O.OCC(O)COC(CCCCCCC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
[D-Ala4]-Substance P...
[DAla4] Substance P (4-11) is an analog of Substance P (Substance P ) that inhibits the binding of 125I-Bolton Hunter-conjugated Eledoisin (Eledoisin) (IC50 of 0.5 μM) and 125I-Bolton Hunter-conjugated Substance P (IC50 of 0.15 μM) to rat brain cortex membranes.
-
Insulin sensitizer C...
Insulin sensitizer C59 is an orally available insulin sensitizer that improves glucose uptake and can be used to study insulin-stimulated GLUT4 translocation.
-
Yadanzigan
Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
Cart
sales@molnova.com